Search results for "pilot"

showing 10 items of 717 documents

Effectiveness of a home-based strengthening program for elderly males in Italy. A preliminary study

2002

Background and aims: The practice of regular physical exercise has been shown to be effective in slowing the age-related progressive functional deterioration. Most exercise trials have been conducted with supervised training programs. The purpose of this study was to investigate the effectiveness of a 4-month home-based strength training on strength, function and personal satisfaction. Methods: Ten elderly men (mean age 68.5 years) were enrolled for home-based training one month after completing a 4-month supervised program; 12 age-matched men served as the control group. Subjects were asked to perform 3 sessions a week consisting of six resistance exercises with elastic bands involving the…

Malemedicine.medical_specialtyAgingActivities of daily livingStrength trainingElbowSatisfactionPhysical exercisePilot ProjectsIsometric exerciseHealth PromotionConcentricPatient satisfactionPhysical medicine and rehabilitationQuality of lifeIsometric ContractionActivities of Daily LivingmedicineHumansExerciseAgedAged 80 and overbusiness.industryHome trainingMuscle strengthHome Care Servicesmedicine.anatomical_structureItalyPatient SatisfactionAging; Home training; Muscle strength; Satisfaction; Strength trainingPhysical therapyQuality of LifeGeriatrics and GerontologyStrength trainingbusiness
researchProduct

Aerobic training and angiogenesis activation in patients with stable chronic heart failure: a preliminary report.

2013

The pathophysiology of chronic heart failure (CHF) involves multiple hystologic and molecular alterations. To determine the effects of physical training on circulating endothelial progenitor cells (EPCs), angiogenesis (angiogenin, angiopoietin-1 and -2, VEGF, Tie-2, SDF-1α) and inflammation (IL-6, CRP), we compared data obtained from 11 CHF pts before and after 3 months aerobic exercise training, to those from 10 non trained CHF pts (CHF-C group, age 64 + 2 years, NYHA 2). At the end of the study, EPCs count and AP-2 serum levels significantly increased in the CHF-TR group. These preliminary data suggest a significant effect of even a short program of physical training on angiogenic activat…

Malemedicine.medical_specialtyAngiogeninBrachial ArteryAngiogenesisHealth Toxicology and MutagenesisClinical BiochemistryNeovascularization PhysiologicCardiovascular disease growth factors/cytokines/inflammatory mediators sports science/exerciseInflammationPilot ProjectsBiochemistryNeovascularizationInternal medicinemedicineAerobic exerciseHumanscardiovascular diseasesProspective StudiesEndothelial dysfunctionAngiogenic ProteinsExerciseAgedHeart Failurebusiness.industryStem CellsEndothelial CellsStroke VolumeStroke volumeMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareExercise TherapyVasodilationTreatment OutcomeHeart failureImmunologyChronic Diseasecardiovascular systemCardiologymedicine.symptombusinessBiomarkerscirculatory and respiratory physiologyBiomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
researchProduct

Ablative fractional laser-assisted photodynamic therapy for lentigo maligna: a prospective pilot study.

2019

Background Lentigo maligna (LM) is an in‐situ form of melanoma carrying a risk of progression to invasive lentigo maligna melanoma (LMM). LM poses a clinical challenge, with subclinical extension and high recurrence rates after incomplete surgery. Alternative treatment methods have been investigated with varying results. Photodynamic therapy (PDT) with methylaminolaevulinate (MAL) has already proved promising in this respect. Objectives To investigate the efficacy of ablative fractional laser (AFL)‐assisted PDT with 5‐aminolaevulinic acid nanoemulsion (BF‐200 ALA) for treating LM. Methods In this non‐sponsored, prospective pilot study ten histologically verified LMs were treated with AFL‐as…

Malemedicine.medical_specialtyBF-200 ALASkin NeoplasmsBiolääketieteet - Biomedicinemedicine.medical_treatmentFractional laserPhotodynamic therapyPilot ProjectsDermatologyLentigo malignalaserhoitoHutchinson's Melanotic Freckle030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineablative fractional laser5-aminolaevulinic acid nanoemulsionAblative casemedicineHumansmelanoomaProspective StudiesLentigo maligna melanomaSubclinical infectionAgedAged 80 and overbusiness.industryRopivacaineMelanomaSisätaudit - Internal medicineAminolevulinic AcidMiddle Agedmedicine.diseaseCombined Modality Therapy3. Good healthInfectious Diseasesphotodynamic therapyfotodynaaminen hoitoPhotochemotherapy030220 oncology & carcinogenesisFemaleRadiologyLaser Therapylentigo malignabusinessmedicine.drugJournal of the European Academy of Dermatology and Venereology : JEADVReferences
researchProduct

Screening for bipolar disorders in Spanish-speaking populations: sensitivity and specificity of the Bipolar Spectrum Diagnostic Scale-Spanish Version.

2010

Background: Bipolar disorder is commonly misdiagnosed, perhaps more so in Latin American and Spanish-speaking populations than in the United States. The Bipolar Spectrum Diagnostic Scale (BSDS) is a 19-item screening instrument designed to assist in screening for all types of bipolar disorder. Methods: The authors investigated the sensitivity of a Spanish-language version of the BSDS in a cohort of 65 outpatients with a diagnosis of bipolar disorder, based on a semi-structured interview and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria. To determine specificity, we assessed a control group of 36 outpatients with diagnosis of unipolar major dep…

Malemedicine.medical_specialtyBipolar Disorderlcsh:RC435-571ArgentinaSpanish speakingPilot ProjectsSensitivity and SpecificityDiagnosis Differentiallcsh:PsychiatryInterview PsychologicalmedicineHumansSingle-Blind MethodBipolar disorderPsychiatryScreening instrumentBipolar spectrum diagnostic scaleDepressive Disorder MajorSpanish versionHispanic or LatinoMiddle Agedmedicine.diseaseUnited StatesDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyCase-Control StudiesEnglish versionCohortMajor depressive disorderFemalePsychologyClinical psychologyComprehensive psychiatry
researchProduct

Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.

2020

Background: Percutaneous left atrial appendage closure (LAAC) exposes to the risk of device thrombosis in patients with atrial fibrillation who frequently have a contraindication to full anticoagulation. Thereby, dual antiplatelet therapy (DAPT) is usually preferred. No randomized study has evaluated nonvitamin K antagonist oral anticoagulant after LAAC, and we decided to evaluate the efficacy and safety of reduced doses of rivaroxaban after LAAC. Methods: ADRIFT (Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure) is a multicenter, phase IIb study, which randomized 105 patients after successful LAAC to eith…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsAntithrombin IIIAtrial AppendagePilot Projects030204 cardiovascular system & hematologyFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRivaroxabanLeft atrialHeart RateInternal medicineAtrial FibrillationMedicineHumansAtrial Appendage030212 general & internal medicineContraindicationBlood CoagulationAgedAppendageAged 80 and overRivaroxabanbusiness.industryDual Anti-Platelet TherapyAtrial fibrillationThrombosisClopidogrelmedicine.diseasePeptide Fragments3. Good healthTreatment OutcomeCardiologyAtrial Function LeftFemaleProthrombinFranceCardiology and Cardiovascular MedicinebusinessBiomarkersPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsPeptide HydrolasesCirculation. Cardiovascular interventions
researchProduct

Monocyte distribution width as a biomarker of sepsis in the intensive care unit: A pilot study.

2020

Background Monocyte distribution width has been recently proposed as a sepsis biomarker in the emergency department. The aim of this study was to assess the role of monocyte distribution width as a diagnostic biomarker of sepsis in the intensive care unit. Methods In this prospective observational study, we included all consecutive patients admitted to the intensive care unit of the University Hospital “P. Giaccone” of Palermo. Patients were classified into three groups according to Sepsis-3 criteria: (1) patients without sepsis; (2) patients developing sepsis during their hospital stay; (3) patients admitted with sepsis. Monocyte distribution width was measured at admission (groups 1, 2, 3…

Malemedicine.medical_specialtyClinical BiochemistryPilot ProjectsMonocyteslaw.inventionSepsislawSepsisMedicineDistribution (pharmacology)HumansProspective StudiesAgedAged 80 and overbusiness.industryMonocyteGeneral MedicineEmergency departmentMiddle Agedmedicine.diseaseIntensive care unitIntensive Care Unitsmedicine.anatomical_structureEmergency medicineBiomarker (medicine)biomarker sepsis ICU MDW monocytesFemalebusinessBiomarkersAnnals of clinical biochemistry
researchProduct

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.

2014

Background Liraglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog, has several non- glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown. Methods A prospective study of 8 months duration in 64 patients with type-2 diabetes and no prior history of coronary artery disease evaluated whether adding liraglutide to metformin affects carotid IMT, measured by color doppler ultrasound. Results After 8 months, fasting glucose decreased by 2.1 mmol/l and HbA1c by 1.9% (p < 0.01 for all). Liraglutide reduced total-cholesterol and triglycerides by 10%, and LDL-cholesterol by 19%, whereas HDL-cholester…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPilot ProjectsType2 diabetesType 2 diabetesCarotid Intima-Media ThicknessCoronary artery diseaseGlucagon-Like Peptide 1Internal medicineDiabetes mellitusLiraglutide Carotid intima-media thickness Cardiovascular risk Type2 diabetesmedicineHumansHypoglycemic AgentsProspective Studiescardiovascular diseasesProspective cohort studyGlycemicAgedOriginal Investigationbusiness.industryLiraglutideLiraglutideMiddle Agedmedicine.diseaseCardiovascular risk3. Good healthMetforminEndocrinologyIntima-media thicknessDiabetes Mellitus Type 2Cardiologycardiovascular systemFemalebusinessCardiology and Cardiovascular Medicinemedicine.drug
researchProduct

Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β-cell protection in individuals with type 2 diabetes

2010

AIM Postprandial release of intact proinsulin (IP) is an independent marker for beta-cell dysfunction in patients with type 2 diabetes. This open-label, parallel-group, two-arm, pilot study compared the beta-cell protective effect of adding insulin glargine (GLA) vs. NPH insulin to ongoing metformin. MATERIAL AND METHODS Overall, 28 insulin-naive type 2 diabetes subjects (mean +/- SD age, 61.5 +/- 6.7 years; diabetes duration, 9.8 +/- 6.5 years; HbA1c, 7.1 +/- 0.5%; BMI, 30.7 +/- 4.3 kg/m(2)) treated with metformin and sulfonylurea were randomized to add once-daily GLA or NPH at bedtime. At baseline and after 3 months, subjects received a standardized breakfast, lunch and dinner, with pre- …

Malemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentInsulin IsophaneInsulin GlarginePilot ProjectsNPH insulinType 2 diabetesNPH insulinDrug Administration ScheduleEndocrinologyInsulin-Secreting CellsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsInsulinintact proinsulinGlycated Hemoglobinbusiness.industryInsulin glargineInsulindigestive oral and skin physiologynutritional and metabolic diseasesFastingOriginal ArticlesMiddle AgedPostprandial Periodmedicine.diseaseMetforminMetforminInsulin Long-ActingEndocrinologyPostprandialDiabetes Mellitus Type 2beta cell stressDrug Therapy CombinationFemalebusinessmedicine.drugBlood samplingDiabetes, Obesity and Metabolism
researchProduct

Interleukin-6 gene promoter –174G/C polymorphism and insulin resistance: a pilot study

2007

Background: The aim of this pilot study was to evaluate the relationship between interleukin-6 promoter -174G/C (IL-6 -174G/C) polymorphism and insulin resistance (IR) in obese patients with coronary heart disease (CHD). Methods: Twenty obese male patients with CHD were selected from a larger database of patients (n=606). IL-6 -174G/C genotype was previously analysed and only homozygotes with the CC genotype (n=10) or GG genotype (n=10) were selected. IR was measured using the homeostasis model assessment for IR (HOMA-IR) method. Results: Differences in age, body mass index, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (HDL-C), triglyceride (T…

Malemedicine.medical_specialtyGenotypemedicine.medical_treatmentClinical BiochemistryCoronary DiseasePilot ProjectsBiologychemistry.chemical_compoundInsulin resistanceRisk FactorsPolymorphism (computer science)Internal medicineGenotypemedicineHumansObesityPromoter Regions GeneticPancreatic hormoneAgedPolymorphism GeneticTriglycerideInterleukin-6InsulinCholesterol HDLBiochemistry (medical)Age Factorsnutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseObesityEndocrinologychemistryCardiovascular DiseasesFemaleInsulin ResistanceBody mass indexClinical Chemical Laboratory Medicine
researchProduct

Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations?

2020

Background and Aims: Although a family history of cancer (FHC) can modify the lifestyle and attitudes towards participation in cancer screening programs, studies on this relationship show mixed results and vary across populations. The objectives of the study were to compare sociodemographic characteristics, history of gastrointestinal (GI) investigations and Helicobacter pylori eradication, and modifiable cancer risk factors between those with FHC and those with no FHC (NFHC), and to investigate the association between FHC and a history of GI investigations.&#x0D; Methods: A total of 3,455 questionnaires from the pilot study of the “Helicobacter pylori eradication and pepsinogen testing for…

Malemedicine.medical_specialtyHealth BehaviorColonoscopyPilot ProjectsLogistic regressionHelicobacter InfectionsScreening programmeRisk FactorsInternal medicineSurveys and QuestionnairesCancer screeningmedicineHumanscardiovascular diseasesFamily historyMedical History TakingEarly Detection of CancerGastrointestinal Neoplasmsbiologymedicine.diagnostic_testHelicobacter pyloribusiness.industryGastroenterologyCancerFaecal occult bloodColonoscopyHelicobacter pyloriPatient Acceptance of Health Caremedicine.diseasebiology.organism_classificationLatviaSocioeconomic FactorsFemalebusinessJournal of gastrointestinal and liver diseases : JGLD
researchProduct